Past exposure to asbestos and combustion products and incidence of cancer among Finnish locomotive drivers.

Por Nokso-Koivisto, P, Pukkala, E
Publicado em 1994

Androgen receptor gene and hormonal therapy failure of prostate cancer.

Por Koivisto, P., Kolmer, M., Visakorpi, T., Kallioniemi, O. P.
Publicado em 1998

Inhalation exposure of rats and mice to 1,3-butadiene induces N6-adenine adducts of epoxybutene detected by 32P-postlabeling and HPLC.

Por Koivisto, P, Adler, I D, Sorsa, M, Peltonen, K
Publicado em 1996

Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.

Por Koivisto, P., Hyytinen, E., Palmberg, C., Tammela, T., Visakorpi, T., Isola, J., Kallioniemi, O. P.
Publicado em 1995

BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland

Por Ikonen, T, Matikainen, M, Syrjakoski, K, Mononen, N, Koivisto, P, Rokman, A, Seppala, E, Kallioniemi, O, Tammela, T, Schleutker, J
Publicado em 2003

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

Por Mononen, N, Ikonen, T, Syrjäkoski, K, Matikainen, M, Schleutker, J, Tammela, T L J, Koivisto, P A, Kallioniemi, O P
Publicado em 2001

Increased risk of cancer in patients with fumarate hydratase germline mutation

Por Lehtonen, H J, Kiuru, M, Ylisaukko‐oja, S K, Salovaara, R, Herva, R, Koivisto, P A, Vierimaa, O, Aittomäki, K, Pukkala, E, Launonen, V, Aaltonen, L A
Publicado em 2006